We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Latest News
454 Life Sciences and the GSC at Washington University Announce Collaborative Research Plan
News

454 Life Sciences and the GSC at Washington University Announce Collaborative Research Plan

Research will be performed on the 454 Life Sciences' Genome Sequencer 20 Systems at the Genome Sequencing Center.
Xceleron and Servier Sign Agreement to Accelerate Drug Development
News

Xceleron and Servier Sign Agreement to Accelerate Drug Development

The Agreement covers the provision by Xceleron of accelerator mass spectrometry services to assist Servier.
MedImmune Licenses BioWa’s POTELLIGENT™ Technology
News

MedImmune Licenses BioWa’s POTELLIGENT™ Technology

BioWa will provide MedImmune with commercial rights to use the technology to enhance antibody-dependent cellular cytotoxicity.
deCODE Announces Appointment of Dr. Linda Buck to Board of Directors
News

deCODE Announces Appointment of Dr. Linda Buck to Board of Directors

Dr. Linda will give valuable contribution to deCODE’s efforts to apply human genetics to make better medicine.
Celera Diagnostics Discovers Genes Associated with Alzheimer's Disease
News

Celera Diagnostics Discovers Genes Associated with Alzheimer's Disease

The study provides valuable insights into the genetic contribution to Alzheimer's disease.
BioTrove and SPRI Expand Lead Discovery Collaboration
News

BioTrove and SPRI Expand Lead Discovery Collaboration

BioTrove will use its RapidFire® Lead Discovery service for assay development and high throughput screening.
Domantis Announces Therapeutic Alliance with Bristol-Myers Squibb
News

Domantis Announces Therapeutic Alliance with Bristol-Myers Squibb

Both companies collaborate to develop domain antibody products.
Study Hints at Role of Stem Cell Genes in Cancers
News

Study Hints at Role of Stem Cell Genes in Cancers

Misregulated embryonic stem cell genes, scientists have reasoned, could cause or advance cancer.
InforSense Initiates Annual 'Open House'
News

InforSense Initiates Annual 'Open House'

Presentations by Customers, Including GlaxoSmithKline and Windber Research Institute, Showcase ROI for InforSense Applications.
Nimblegen Systems Raises Another $8.2 Million in Financing
News

Nimblegen Systems Raises Another $8.2 Million in Financing

The Company has raised a total of $50 million since its inception in 1999.
Advertisement